Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (CSE: NM ) N/A UNCHANGED Last Price Updated: 9:49 AM EDT, Jun 13, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 0.2100 (1,000) Ask (Size) 0.3800 (2,000) Prev. Close 0.2950 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies December 16, 2021 Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing... Via FinancialNewsMedia Topics Artificial Intelligence Exposures Artificial Intelligence Novamind Opens New Clinic with Specialized Focus on Substance Use Disorders December 06, 2021 Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza TORONTO, ON / ACCESSWIRE / December 6, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the... From Novamind Inc. Via AccessWire Topics Death Exposures COVID-19 Death Performance More News Read More Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6 December 02, 2021 From Novamind Inc. Via AccessWire Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network December 01, 2021 From Novamind Inc. Via AccessWire Novamind Reports Fiscal Q1 Financial Results and Operating Highlights November 29, 2021 From Novamind Inc. Via AccessWire Novamind Unveils New Logo and Invests in Unified Brand November 24, 2021 From Novamind Inc Via AccessWire Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona November 16, 2021 From Novamind Inc. Via AccessWire Novamind to Present at International Summit on Psychedelic Therapies for Mental Illness November 15, 2021 From Novamind Ventures Inc. Via AccessWire Novamind Enters New Lease Agreement Responding to Patient Demand November 12, 2021 From Novamind Inc. Via AccessWire Novamind Secures Insurance Coverage for Ketamine from Four Major Payors November 10, 2021 From Novamind Inc. Via AccessWire Exposures Product Safety Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading November 08, 2021 From Novamind Inc. Via AccessWire Novamind Reports FY2021 Financial Results and Operating Highlights November 05, 2021 From Novamind Inc. Via AccessWire Exposures COVID-19 Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements November 04, 2021 From Novamind Inc. Via AccessWire Novamind Unveils Stealth Mode Investment in Alto Neuroscience October 22, 2021 From Novamind Ventures Inc. Via AccessWire Novamind Granted DEA Licenses for Psilocybin Research October 13, 2021 From Novamind Inc. Via AccessWire Novamind to Present at LD Micro and KCSA Conferences October 08, 2021 From Novamind Inc. Via AccessWire Novamind Launches New Psychedelic Palliative Care Program October 07, 2021 From Novamind Inc. Via AccessWire Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021 October 04, 2021 From Novamind Ventures Inc. Via AccessWire Novamind Opens 6th Integrative Psychiatry Clinic, Adds 3rd Clinical Research Site September 30, 2021 From Novamind Inc. Via AccessWire Novamind Announces DTC Eligibility for its Common Shares September 24, 2021 From Novamind Inc. Via AccessWire Novamind to Present at Benzinga Healthcare Conference September 23, 2021 From Novamind Inc. Via AccessWire Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF September 20, 2021 From Novamind Inc. Via AccessWire Novamind to Present at Life Sciences Investor Forum September 14, 2021 From Novamind Inc. Via AccessWire Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial September 13, 2021 From Novamind Inc. Via AccessWire Novamind Uplists to OTCQB Venture Market September 09, 2021 From Novamind Ventures Inc. Via AccessWire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.